Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Esophageal Neoplasms × Rocuronium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2 Uterine Prolapse 1 Urinary Bladder Neoplasms 1 Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1 Renal Insufficiency, Chronic 1 Neuromuscular Blockade 1 Muscle Hypotonia 1 Melanoma 1 Lung Neoplasms 1 Leiomyoma 1 Intestinal Obstruction 1 Esophageal Neoplasms 1 Endometriosis 1 Endobronchial Metastases 1 Cholecystitis 1 Anesthesia 1

Interventions

Cisplatin 146 Fluorouracil 123 Paclitaxel 114 Radiotherapy 105 Oxaliplatin 80 Docetaxel 65 Carboplatin 60 Irinotecan 55 pembrolizumab 53 Leucovorin 53 Capecitabine 52 Radiation 42 Surgical Procedures, Operative 31 Esophagectomy 27 Drug Therapy 27 Cetuximab 24 Nivolumab 21 Bevacizumab 21 Trastuzumab 19 Neoadjuvant Therapy 19 camrelizumab 17 S 1 (combination) 17 Chemoradiotherapy 16 Albumin-Bound Paclitaxel 16 Magnetic Resonance Spectroscopy 14 tislelizumab 13 Epirubicin 13 Cyclophosphamide 13 Taxes 12 Radiotherapy, Intensity-Modulated 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02320734 2016-09-19

DEPTH

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡